Price Targets: Developments for Worldline, Carrefour, Air France, and Others
This Monday sees adjustments in twelve French and European stocks, with significant movements for Worldline, experiencing a dramatic reversal at Jefferies, and Maisons du Monde, with a sharp drop in target at Oddo BHF.
Above Their Targets
Above their target: 6 stocks · Covered stocks: 63
Stocks above their target: BE SEMICONDUCTOR (-11.2%) · ASM INTERNATIONAL (-6.2%) · ASML HOLDING (-5.3%) · NN GROUP (-3.9%) · MICHELIN (-2.6%) · BOLLORE (-0.3%)
Largest target/price gaps:
CSG — target price 30.75 euros — gap target/price: +114.8%
PROSUS — target price 66.00 euros — gap target/price: +72.7%
WOLTERS KLUWER — target price 99.00 euros — gap target/price: +68.2%
CAPGEMINI — target price 150.00 euros — gap target/price: +67.6%
EXOR NV — target price 109.00 euros — gap target/price: +66.3%
Worldline: a 180-degree turn at Jefferies, switching from a target of 0.40 euro to 17.20 euros while upgrading from 'sell' to 'buy'. Invest Securities also adjusts its target from 10.60 to 11 euros and upgrades from 'sell' to 'hold'. 2 analysts had already raised their targets in the past 10 days.
UCB: UBS maintains its 'buy' recommendation but reduces the target from 330 to 320 euros. Median consensus at 299.50 euros — target/price gap: +19.9% (current price: 249.70 euros). An analyst had lowered the target on June 15.
Gecina: UBS raises the target from 80 to 83 euros and confirms its 'buy' recommendation.
Air France-KLM: from 9 to 11 euros at Deutsche Bank, which sets a 'hold' recommendation. UBS sets a new target at 13.50 euros. An analyst had raised the target on June 19.
Maisons du Monde: a dramatic drop in target by Oddo BHF, from 2.70 to 0.28 euro while maintaining a 'neutral' recommendation.
LISI: Berenberg initiates coverage with a 'buy' recommendation and a target of 81 euros.
Carrefour: Morgan Stanley starts coverage at 'overweight' with a target of 20.10 euros.
bioMérieux: RBC Capital lowers the target from 100 to 75 euros while maintaining 'market perform'. An analyst had already reduced the target on June 17.
Ayvens: BNP Paribas Exane raises the target from 13.50 to 14 euros (recommendation 'outperform'). However, an analyst had lowered the target on June 14.
Arverne Group: Portzamparc starts coverage at 'buy' with a target of 10.60 euros.
ABL Diagnostics: ALLInvest initiates coverage at 'buy', target 8.40 euros. An analyst had raised the target on June 19.
ASM International: Citi confirms 'buy' and maintains the target at 1,000 euros. The median consensus also stands at 1,000 euros — target/price gap: -6.2% (current price: 1,066.50 euros). 3 analysts had raised their targets in the past 10 days, the last movement on June 19.
Transgene: Invest Securities reiterates its 'buy' recommendation and target at 1.70 euro.
